pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
pre-IPO PHARMA NEWS
Business
09/27/23
Venatorx Pharmaceuticals to Present at IDWeek 2023
09/27/23
Omniose Awarded NIH Grant of up to $3.0 Million to Develop Vaccines against Group B Streptococcus
09/27/23
Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
09/27/23
Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million
09/27/23
Flamingo Therapeutics Announces Participation at Upcoming Investor and Industry Conferences
09/27/23
Evommune Announces Strategic Collaboration with Maruho to Develop and Commercialize MRGPRX2 antagonist EVO756 in Japan
09/27/23
Azurity Pharmaceuticals Acquires Slayback Pharma
09/26/23
Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation
09/26/23
Capstan Therapeutics to Participate in Upcoming Industry Conferences
09/26/23
Alzheon To Present Pivotal Program of Oral ALZ-801/Valiltramiprosate at Singularity Conference, Goldman Sachs Alzheimer’s Disease Day, and BIO Investor Forum
09/25/23
Sustainable Packaging Disruptors Bluebird and Pact Collective Partner to Drive the Beauty Industry Toward Circularity
09/25/23
Bexion Pharmaceuticals, Inc. to Participate in the 2023 Cantor Global Healthcare Conference
09/22/23
Qihan Biotech announces the completion of pre-Series B financing for developing stem cell-derived cell therapy products with high-throughput multiplexable genome editing
09/22/23
MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil
09/21/23
Transcend Therapeutics and Yale awarded U.S. Department of Defense grant to study methylone for PTSD
09/21/23
Maze Therapeutics to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
09/21/23
Lynk Pharmaceuticals Completes Series C2 Financing Round, with Total C Round Funding of 322 Million RMB USA - English APAC - English
09/20/23
Capsida Biotherapeutics to Present at Jefferies Cell and Genetic Medicine Summit and the 2023 Cell and Gene Meeting on the Mesa
09/19/23
ReCode Therapeutics Announces Closing of Extension to Series B Financing
09/19/23
RayzeBio, Inc. Announces Closing of Upsized $358 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Science
09/29/23
Therapeutic Solutions International Announces Paradigm Shifting Immunotherapy Product: Tolerogenic Neutrophils
09/29/23
Atamyo Therapeutics Announces participation in Conferences and Key Scientific Communications on its LGMD programs
09/28/23
First Patient Dosed in Phase 1b Clinical Trial of Synthekine’s α/β Biased IL-2, STK-012, for Treatment of Solid Tumors
09/28/23
ProfoundBio Announces Upcoming Scientific Presentations at SITC 2023
09/28/23
Nanoscope Therapeutics to Present at the 4th Annual Gene Therapy for Ophthalmic Disorders Summit
09/28/23
IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO (Equecabtagene Autoleucel) at IMS 2023
09/28/23
Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO (Equecabtagene Autoleucel) at IMS 2023 USA - English APAC - English
09/28/23
Fractyl Health to Present Pioneering Data on Revita and Rejuva Programs at the European Association for the Study of Diabetes (EASD) 2023 Scientific Congress
09/27/23
XNK Therapeutics presented two posters at the NK2023 conference in Oslo USA - English USA - English
09/27/23
Tallac Therapeutics Announces Two Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
09/27/23
HotSpot Therapeutics to Present Preclinical Data from CBL-B Program at 2023 Society for Immunotherapy of Cancer Annual Meeting
09/27/23
CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19
09/27/23
Adcentrx Therapeutics Announces First Patient Dosed in the Phase 1a/b Study of ADRX-0706, a Novel ADC Targeting Nectin-4 for the Treatment of Advanced Solid Tumors
09/26/23
Recent Nature publications highlight the groundbreaking performance of RareCyte's Orion Spatial Biology platform
09/26/23
Elpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of Anti-LILRB2 Antibody ES009 in Australia
09/26/23
Cantex and Allegheny Health Network Announce Initiation of a Phase 1/2 Study of Azeliragon in Patients Refractory to First-Line Treatment of Metastatic Pancreatic Cancer
09/26/23
AM-Pharma Announces Updated Clinical Development Strategy
09/25/23
Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262, a First-in-Class Oral MRGPRX2 Antagonist, in Chronic Inducible Urticaria
09/25/23
AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib (Luminate) First-in-Class Candidate for the Treatment of Intermediate Dry AMD USA - English APAC - English
09/22/23
PHYLEX BIOSCIENCES ANNOUNCES NIPAH VIRUS VACCINE INITIATIVE WITH ITS NANOPARTICLE mRNA VACCINE TECHNOLOGY
People
09/28/23
PIC Therapeutics Expands its Team with the Addition of Translational Biology Oncology Leader, Richard Gedrich, PhD as Chief Development Officer
09/27/23
SaNOtize’s Board Appoints Steven Basta as New Chief Executive Officer
09/27/23
Chroma Medicine Strengthens Leadership with the Appointment of Biotech Business Leader Michael A. Kelly to its Board of Directors
09/26/23
NextRNA Therapeutics Strengthens Board of Directors with Appointment of Lori Friedman, PhD
09/21/23
Nanoscope Therapeutics Strengthens Clinical and Regulatory Expertise With Appointment of Samuel Barone, M.D., as Chief Medical Officer
09/21/23
Anavo Therapeutics Strengthens Management Team
09/21/23
Accent Therapeutics Bolsters Leadership Team with Key Executive Hires
09/19/23
OcuTerra President and CEO Kerrie Brady Named to 2023 PharmaVoice 100 List of Most Inspiring Leaders
09/19/23
AuraVax Therapeutics recognizes its academic collaborator at the University of Houston for address at Keystone Conference
09/18/23
Therapeutic Solutions International Recruits Internationally Renowned Stem Cell Clinician and San Diego Top Doctor to Scientific Advisory Board
09/18/23
Acepodia Announces Nobel Laureate Carolyn Bertozzi, Ph.D., as Chief Scientific Advisor
09/14/23
Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board
09/14/23
Fractyl Health Welcomes Dr. Timothy Kieffer as Chief Scientific Officer
09/12/23
Confo Therapeutics Appoints Stephen Dowd as Chief Business Officer
09/07/23
Vividion Therapeutics Names Shawn Rose as Chief Development Officer
09/07/23
Rapport Therapeutics Appoints Chief Operating Officer and Scientific Advisory Board Member
09/07/23
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
09/07/23
Anokion Strengthens its Senior Leadership with Promotions and New Appointment
09/06/23
Allay Therapeutics Appoints Nicole Vitullo to Board of Directors
09/05/23
Phanes Therapeutics Announces the Establishment of Oncology Clinical Advisory Board
09/05/23
AIVITA Biomedical CEO Dr. Hans Keirstead to Deliver Keynote at Advanced Therapies Europe
08/31/23
Akston Biosciences Receives 2023 Most Innovative Award at Animal Health Summit